National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group ReportMadan Jagasia, Mary E.D. Flowers, Hildegard Greinix et al.|Biology of Blood and Marrow Transplantation|2014Cited by 5.4k
Ipilimumab for Patients with Relapse after Allogeneic TransplantationMatthew S. Davids, Robert J. Soiffer, Haesook T. Kim et al.|New England Journal of Medicine|2016Cited by 595
Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: Thrombotic Microangiopathy after Hematopoietic Stem Cell TransplantationVincent T. Ho, Sergio Giralt, Corey Cutler et al.|Biology of Blood and Marrow Transplantation|2005Cited by 458
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant ResearchSally Arai, Yoshiko Atsuta, Mukta Arora et al.|Biology of Blood and Marrow Transplantation|2014Cited by 435
Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid LeukemiaYi‐Bin Chen, Robert J. Soiffer, Shuli Li et al.|Biology of Blood and Marrow Transplantation|2014Cited by 234